期刊文献+

玻璃化低温保存卵巢癌细胞的配方及优化降温过程参数

Formulation for vitrification solution and cooling process parameters in cryopreservation of human ovarian cancer COC1 cells
下载PDF
导出
摘要 实验采用玻璃化低温保存方法和程序降温方法来研究COC1细胞的低温保存效果。玻璃化低温保存:采用3种玻璃化溶液,①质量浓度为400g/L聚乙烯基吡咯烷酮+质量浓度为200g/L蔗糖+质量浓度为100g/L甘露醇。②VS55。③质量浓度为300g/L聚乙烯基吡咯烷酮+质量浓度为200g/L海藻糖。每种溶液以不同的比例与细胞悬液混合均匀,投入液氮保存。程序降温法:以甘油和二甲基亚砜为低温保护剂,分别以不同的比例添加到含有细胞悬液的冻存管中。然后采用两步降温法,投入液氮保存。结果玻璃化溶液(质量浓度为300g/L聚乙烯基吡咯烷酮+质量浓度为200g/L海藻糖)保存COC1细胞可以获得最高细胞存活率,且玻璃化方法取得的存活率高于程序降温法。初步表明,用玻璃化方法长期保存卵巢癌细胞具有一定的可行性和前景,使COC1细胞能够最大限度的保持较好的生理功能。 This experiment was to study the cryopreservative effect of vitrification and programmed cooling method on human ovarian cancer COC1 cells. Three kinds of vitrification solutions were used in vitrification. (1)400 g/L polyvinylpyrrolidone + 200 g/L sucrose + 100 g/L mannitol; (2)VS55; (3)300 g/L polyvinylpyrrolidone + 200 g/L trehalose. The three kinds of vitrification solutions were mixed with COC 1 cells suspensions at different proportion, respectively. Then the samples were preservd in liquid nitrogen. Programmed cooling method: The glycerol and Dimethylsulfoxide, as cryoprotective agents, were mixed with COC1 cells suspensions at different concentration, respectively. After cooled by two step method, the samples were preserved in liquid nitrogen. The experiment found that the vitrification solution composed of 300 g/L polyvinylpyrrolidone + 200 g/L trehalose could obtain the highest cell viability of human ovarian cancer COC 1 cells. And the viability of COC 1 cells preserved by vitrification was higher than that preserved by programmed cooling method. The results indicted that long-term cryopreservation of human ovarian cancer COC 1 cells by using vitrification has the feasiblility and good prospects, and the vitrification can maintain the physiological function of COC 1 cells to the maximum extent.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第46期9153-9155,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金(50576059)~~
  • 相关文献

参考文献15

  • 1Lian LJ.Zhonghua Fuchanke Zazhi 1996;31 (2):67-70
  • 2连利娟.卵巢癌化疗的现况与趋向[J].中华妇产科杂志,1996,31(2):67-70. 被引量:39
  • 3Tao YS.Zhongguo Shouyi Zazhi 2006;30(1):22-23
  • 4陶玉顺.浅谈现代生物技术在医药及动物疫病诊断防制中的应用[J].贵州畜牧兽医,2006,30(1):21-22. 被引量:3
  • 5Svendsen CN, Smith AG. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 1999;22(8):357-364
  • 6Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002;91(10):866-876
  • 7Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145- 1147
  • 8Shamblott MJ, Axelman J, Wang S, et al.Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 1998;95(23): 13726-13731
  • 9Wang X,Hua ZZ,Yang GH,et al.Diwen Gongcheng 2003;(1): 17-22
  • 10王欣,华泽钊,杨光辉,崔磊,刘伟,曹谊林,程启康.培养9天的组织工程化真皮低温保存的研究[J].低温工程,2003(1):17-22. 被引量:4

二级参考文献16

  • 1殷震.生物技术及其在动物疫病防制上的应用[J].福建畜牧兽医,1997(1):1-3. 被引量:2
  • 2F.Elendorff,郭宝林 译.生物技术在养禽业中应用的现状与展望[J].国外畜牧科技,1997,24(1):41-43. 被引量:4
  • 3杨光辉 商庆新 曹谊林.脱细胞真皮基质复合表皮细胞移植修复全层皮肤缺损的实验研究[A]..第二届全国组织工程学术大会论文汇编[C].广州,2000,12.487-489.
  • 4Dawn R. Applegate, Kang Liu, Jonathan Mansbridge. Practical Considerations for Large-scale Cryopreservation of a Tissue Engineered Human Dermal Replacement. Advances in Heat and Mass Transfer in Biotechnology, 1999, Vol. 44:71 -91.
  • 5Ben-Bassat H, Strauss N, Ron M, et al. Transplantation performance of human skin eryopreserved by programmed or stepwise freezing and stored at -80degrees C or- 180 degrees C. J Bum Care Rehabil, 1996, Sep-Oct, 17 (5): 421-8.
  • 6Keamey J N, Wheldon L A, Gowland G. Effects of cryobiological variables on the survival of skin using a defined marine model.Cryobiology, 1990, Apr, 27 (2): 164-70.
  • 7Teasdale B, Sieber V K, Riches D J, et al. Cayopreservation of cultured dermal fibroblast impregnated eollagen gels. Bums, 1993,Oct, 19 (5): 406-10.
  • 8Mansbfidge J, Liu K, Patch R, et al. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissue Eng, 1998, Winter, 4 (4) : 403-14.
  • 9蔡霞 曹谊林 商庆新 等.组织工程技术修复猪全层皮肤缺损[A]..第二届全国组织工程学术大会论文汇编[C].广州,2000,12.492~495.
  • 10张国红.论现代生物技术在兽医兽药上的应用[J].中国兽医杂志,1997,23(11):52-53. 被引量:4

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部